DeutschNewstral
Article
kansascity.com on 2017-06-22 00:18
Cross-country trip calls attention to huge price spike for muscular dystrophy drug
Related news
Muscular Dystrophy Drug Sales Could Start in 2016theledger.com
FDA committee votes against approval of controversial muscular dystrophy drugWashington Post- NPotential treatment for muscular dystrophynews.harvard.edu
Duchenne muscular dystrophy drug could get OK for U.S. sales in 2016Chicago Tribune- RJournalist With Muscular Dystrophy Has Gritrocklintoday.com
Winn-Dixie raises funds for Muscular Dystrophywsfa.com
FDA delays decision on muscular dystrophy drugThe Salt Lake Tribune
Muscular Dystrophy Drugs Face New FDA Questionswsj.com- Muscular Dystrophy Day at the FDAwsj.com
Muscular Dystrophy Association seeks post-telethon identityseattletimes.com- FDA tentatively OKs first muscular dystrophy drugThe Salt Lake Tribune
- Winn-Dixie raises fund for Muscular Dystrophywsfa.com
Green light for muscular dystrophy drugBBC
FDA approves first muscular dystrophy drugreviewjournal.com
UCLA professors launch campaign for son’s Duchenne muscular dystrophydailybruin.com- HFDA Rejects Muscular Dystrophy Drug, Says It Doesn’t Workhamodia.com
- AKansas youth camp for muscular dystrophy moves to Missouriapnewsarchive.com
FDA delays high-stakes decision on muscular dystrophy drugwkrg.com
In surprise decision, US approves muscular dystrophy drugabqjournal.com- BA Small Forward Step for Sarepta's Muscular Dystrophy Treatmentsbarrons.com